Sorafenib is a multikinase inhibitor studied for its role in cancer treatment. It is characterized as an aromatic, heterocyclic compound containing amide, ether, and halogen functional groups.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 284461-73-0
Sorafenib tosylate
active pharmaceutical ingredient
Regorafenib
active pharmaceutical ingredient
Regorafenib monohydrate
active pharmaceutical ingredient
4-[4-[[[[2-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
Pharmaceutical reference standard intermediate
3-Chloroanisole
n.a
Methyl 3,5-dichloro-4-hydroxybenzoate hydrate
n.a
HEPTYLBORONIC ACID
n.a
1-(2-(Ethylthio)ethyl)-2-methyl-5-nitro-1H-imidazole
n.a
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
MLDQJTXFUGDVEO-UHFFFAOYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F